In the past few decades, various studies, including epidemiological studies, randomized controlled trials, meta-analyses, and metabolomics and proteomics studies, have confirmed that high circulating Lp(a) levels contribute to myocardial infarction, peripheral arterial disease, and stroke [[23], [24], [25], [26]]. This evidence concerns the gene LPA and Stroke.